| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/05/2004 | CN1493315A Medicine for treating chronic hepatitis B |
| 05/05/2004 | CN1493314A Chinese herbal medicine preparation for anti inflammation, detumescence and relieving pain |
| 05/05/2004 | CN1493312A Chinese medicine for treating liver disease |
| 05/05/2004 | CN1493310A Medicine for treating chronic colonitis |
| 05/05/2004 | CN1493307A Fatty liver eliminating pill and its preparation process |
| 05/05/2004 | CN1493305A Intestine micro ecological regulating agent |
| 05/05/2004 | CN1493303A Extraction method of scorpion active protein liquid |
| 05/05/2004 | CN1493301A Application of 6-methocy bideoxy bideoxy guanosine in preparation of antihepatitis B medicine |
| 05/05/2004 | CN1493300A Argimycin oral colon orientation administration composition and use |
| 05/05/2004 | CN1493296A Hemsleya amabilis drip pill and its preparation method |
| 05/05/2004 | CN1493295A Oleanolic acid drip pill and its preparation method |
| 05/05/2004 | CN1493294A Diammonium glycyrrhizinate freeze dried powder ampoul agent and its preparation method |
| 05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
| 05/05/2004 | CN1493278A Silymarin behenic acid glyceride lipid nano particle oral solution dosage and its preparation method |
| 05/05/2004 | CN1148440C Feed product |
| 05/05/2004 | CN1148367C Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 05/05/2004 | CN1148355C Pyridazin-3-one derivatives and medicines containing the same |
| 05/05/2004 | CN1148350C Novel VLA-4 inhibitor: oMePUPA-V |
| 05/05/2004 | CN1148227C Therapeutic compound and its application |
| 05/05/2004 | CN1148215C Kidney benefiting belt |
| 05/05/2004 | CN1148207C Medicine for strengthening physique and resisting senility |
| 05/05/2004 | CN1148196C Buccal red deer horn tablet |
| 05/05/2004 | CN1148194C New use of polyunsaturated lecithin |
| 05/05/2004 | CN1148179C 20-Hete antagonists and agonists |
| 05/05/2004 | CN1148176C Compsn. contg. cinnamic acid derivatives for preventing or treating elevated blood lipid level-related diseases |
| 05/04/2004 | US6730702 Sulfodehydroabietic acid monosodium salt pentachloride; prophylactic or therapeutic effect thereof on intestinal mucosal injury |
| 05/04/2004 | US6730696 Phospholipid derivatives of non-steroidal anti-inflammatory drugs |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730685 H+,k+-atpase inhibitor in a water free solvent; ready-to-use solution for parenteral administration |
| 05/04/2004 | US6730676 Central nervous system disorders; cognition activators |
| 05/04/2004 | US6730664 The side-effects of chemotherapy are suppressed or reduced |
| 05/04/2004 | US6730661 Non-digestible dextrans, hydrolysed (galacto)mannans and/or hydrolysed (gluco)mannans; reduce the uptake of high molecular weight substances, allergens and microorganisms through the intestinal wall |
| 05/04/2004 | US6730519 Method of preparing delta-9-tetrahydrocannabinol |
| 05/04/2004 | US6730505 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 05/04/2004 | US6730476 Methods of diagnosing early-onset menopause |
| 05/04/2004 | CA2296178C Human intestinal npt2b |
| 05/04/2004 | CA2132150C Antiulcer agent and adhesion inhibitor for helicobacter pyroli |
| 04/29/2004 | WO2004035740A2 Aromatic bicyclic heterocyles to modulate 1l - 12 production |
| 04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
| 04/29/2004 | WO2004035090A1 Gastric acid secretion inhibiting composition |
| 04/29/2004 | WO2004035078A1 Treatment of inflammatory bowel disease |
| 04/29/2004 | WO2004035077A1 Phosphoprotein preparations for bioactive metal ion delivery and teeth remineralisation |
| 04/29/2004 | WO2004035052A1 Stable solid preparations |
| 04/29/2004 | WO2004035042A1 New use of no donating nsaids |
| 04/29/2004 | WO2004035029A1 Edible phosphoprotein film |
| 04/29/2004 | WO2004035008A2 Treatment of infections and other disorders |
| 04/29/2004 | WO2004034957A2 Methods for treatment of helicobacter pylori-associated disorders |
| 04/29/2004 | WO2004019868A3 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 04/29/2004 | WO2004016101A3 Compositions comprising dietary fat complexer and methods for their use |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2004007770A3 Method for diagnosis of intestinal-type gastric tumors |
| 04/29/2004 | WO2003104485A3 Light emitting microorganisms and cells for diagnosis and therapy of diseases associated with wounded or inflamed tissue |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003099823A3 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003097649A3 1-oxa-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof |
| 04/29/2004 | WO2003086282A3 Nitric oxide donors, compositions and methods of use |
| 04/29/2004 | WO2003082798A8 Natural compounds and derivatives thereof for the prevention and treatment of cardiovascular, hepatic and renal diseases and for cosmetic applications |
| 04/29/2004 | WO2003013537A9 Irinotecan for treatment of cancer |
| 04/29/2004 | WO2003013536A9 Methods for treatment of cancer using irinotecan based on ugt1a1 |
| 04/29/2004 | WO2003013535A9 Use of irinotecan for improved treatment of cancer based on mdr1 |
| 04/29/2004 | WO2003013534A9 Methods for the treatment of cancer with irinotecan based on cyp3a5 |
| 04/29/2004 | WO2003013533A9 Methods for improved treatment of cancer with irinotecan based on mrp1 |
| 04/29/2004 | WO2003009807A3 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 04/29/2004 | WO2003003004A3 Method for identifying compounds the specifically deplete mast cells |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002043771A9 Conjugates of glycosylated/galactosylated peptide |
| 04/29/2004 | WO2002043649A8 Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO2001082953A8 Methods for treatment of diseases associated with inflammation under non-ischemic conditions |
| 04/29/2004 | US20040082805 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 04/29/2004 | US20040082798 Novel amino dicarboxylic acid derivatives with pharmaceutical properties |
| 04/29/2004 | US20040082791 Crystals of benzimidazole compounds |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082787 Chemical compounds |
| 04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
| 04/29/2004 | US20040082664 Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 04/29/2004 | US20040082661 Urea derivatives having vanilloid receptor (vr1) antagonist activity |
| 04/29/2004 | US20040082658 Side-chain halogenated amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082630 1g(a)-Amino-n-hydroxy-acetamide derivatives |
| 04/29/2004 | US20040082623 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |
| 04/29/2004 | US20040082605 Use |
| 04/29/2004 | US20040082603 2,3-Dihydro-isoindol-1-one derivatives |
| 04/29/2004 | US20040082602 Kinase inhibitor; analgesics; antiarthritic agents; antihistamines; gastrointestinal disorders |
| 04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
| 04/29/2004 | US20040082595 Antiproliferative agents; antitumor agents; cyclin-dependent kinase inhibitor |
| 04/29/2004 | US20040082589 Quinoline derivatives as nk-3 and nk-2 antagonists |
| 04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
| 04/29/2004 | US20040082582 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
| 04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082548 Cardiovascular disorders; Alzheimer's disease; anticholesterol agents |
| 04/29/2004 | US20040082524 Use of aivlosin, 3-O-acetyl-4''-O-isovaleryl-tylosin and pharmacologically acceptable derivatives; treatment of necrotic enteritis in poultry and Lawsonia infections, Mycoplasma diseases and swine dysentery in pigs |